Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rise in incidence of gastrointestinal disorders
3.2.1.2 Growing demand for related over-the-counter products
3.2.1.3 Changes in natural food habits
3.2.2 Industry pitfalls & challenges
3.2.2.1 Availability of alternative therapies for gastrointestinal diseases
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Digestive medicines
5.3 Remedies against gastrointestinal complaints
5.4 Natural and synthetic agents
Chapter 6 Market Estimates and Forecast, By Age Group, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Adult
6.3 Pediatric
Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Offline
7.3 Online
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 Bayer AG
9.3 C.H. Boehringer Sohn AG & Co. KG.
9.4 China Resources Pharmaceutical Group Limited
9.5 Eli Lilly and Company
9.6 GlaxoSmithKline plc
9.7 Johnson & Johnson
9.8 Menarini Group
9.9 Merck & Co, Inc.
9.10 Pfizer Inc.
9.11 The Procter & Gamble Company
9.12 Reckitt Benckiser Group plc (RB)
9.13 Sanofi S.A.
9.14 Taisho Pharmaceutical Holdings Co., Ltd.
9.15 Takeda Pharmaceutical Company Limited
